A “crackdown” on alternative access for TAVI

  The transfemoral approach is—by far—the most desirable access route for transcatheter aortic valve implantation (TAVI) for eligible patients; it was used in the TAVI...

NeoChord raises additional financing to drive catheter‐based programme development

NeoChord has announced that it has secured additional funding as an extension of its Series D equity financing, which was announced in November of...

Lotus Edge becomes third TAVI device on US market

Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve implantation (TAVI) system. It is approved for patients with severe...

TAVI company Tioga Medical closes US$15M in series A financing

Tioga Medical—a newly formed Shifamed portfolio company—has announced the closing of its series A preferred stock financing, raising a total of US$15M. According to...

Adrian Banning

Robert W Yeh

Olaf Wendler

(Visited 2,688 times, 1 visits today)